Finally, for individuals aged 40 to 75 years with HIV and diabetes mellitus, the panel recommends initiating moderate intensity statin therapy. Clinicians should also evaluate other risk factors that may warrant consideration of high-intensity statin therapy.1 The REPRIEVE Trial The REPRIEVE study was...
New guidelines on the treatment of cholesterol highlight four groups of people who will most likely benefit from statin therapy, and emphasize the need to tailor stain therapy to meet the individualized needs of each patient.doi:http://medicaleconomics.modernmedicine.com/node/403960M. Nierengarten...
"We don't have great data on the efficacy of statin medications in the elderly so the guidelines drew a cut-off for the recommendations at age 75," Miedema said. "This is understandable, but it kind of leaves clinicians in the dark as to what to do with healthy elderly patients, who ...
Eligibility for statin therapy in primary prevention: discrepancies using different guidelines in a population-based study in SwitzerlandDavid NanchenArnaud ChioleroJacques CornuzMathieu FirmannManuel MarquesVidal PedroVincent MooserFred PaccaudGérard Waeber...
to do with healthy elderly patients, who are often at high risk for heart attacks and strokes," Miedema said. "We clearly need more research looking at the best way to determine who should and should not take a statin, as well as the risks and benefits ofstatin therapyin elderly patients...
In elderly patients, as a rule, blood pressure control should be performed in accordance with their target (65–74 years: o140/90 mm Hg; 75 years or older: o150/90 mm Hg). If they tolerate treatment, a blood pressure of o130/80 mm Hg should be carefully targeted. With regard to ...
This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on statin use for prevention of cardiovascular
Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA, 288 (2002), pp. 462-467 View in ScopusGoogle Scholar 95 J. Cramer, R. Rosenheck, G. Kirk, W. Krol, J. Krystal, VA Naltrexone Study Group 425 Medication compliance feedback and monitoring in ...
7.5%. In total, 2615 participants (36%; 867 women) were eligible for statins based on the new guidelines. Of these, 171 women (20%) and 154 men (9%) were reclassified downward (as not eligible for statin therapy) using a recalibrated ASCVD estimator. In the latter group, 18 women ...
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003;26(6):1796-1801. doi:10.2337/diacare.26.6.1796 PubMedGoogle ScholarCrossref 38. Sanders GD, Neumann PJ, Basu A, et al. ...